Luminex Goes to Direct Sales Channel for MDx | GenomeWeb

NEW YORK (GenomeWeb News) – Luminex will be offering its molecular diagnostics directly to customers starting Jan. 1, 2013, the company said on Tuesday at its annual investor day conference.

The decision comes as Luminex's distribution deals with Abbott and Thermo Fisher Scientific expire at the end of this year and the Austin, Texas-based firm plans several new product launches in the US.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: parent-of-origin effects, framework to uncover clinically important mutations from whole genome sequence data, and more.

A survey of Cincinnati schoolchildren finds teenagers want to know their genetic predisposition to disease, LiveScience reports.

More and more universities are helping their researchers patent their inventions, the Los Angeles Times reports.

Cancer Research UK unveils seven 'grand challenges' that it will fund researchers to tackle.